Advertisement

PharmacoEconomics & Outcomes News

, Volume 494, Issue 1, pp 4–4 | Cite as

Infliximab dose escalation not uncommon during first year in RA

Clinical study
  • 8 Downloads

Keywords

Rheumatoid Arthritis Arthritis Methotrexate Infliximab Health Economic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2006

Personalised recommendations